TCL Archive Preliminary Study Results Show DES In Utero Exposure May Not Be Threat Originally Feared February 17, 1978
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s January 17, 1992
TCL Archive In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief April 5, 1974
